Revelation Biosciences
Financial ratios & Valuation

Historical Multiples (2019 – 2023)

2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-24.40K-56.07-8.39-0.33-28.47-0.01-32.23
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-24.40K26.80-1.01K3.400.510.31-492.72
Price/Cash Flow ratio
N/A-425.11-9.07-0.31-0.47-0.01-217.09
Price/Free Cash Flow ratio
N/A-425.11-8.97-0.31-0.47-0.01-217.04
Price/Earnings Growth ratio
N/A-0.00-0.010.000.280.00-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
4724.02%0.23%1.83%0.32%N/AN/A1.07%
Return on Assets
-16.04%-35.28%-586.95%-196.14%-0.98%-350.34%-468.64%
Return On Equity
100%-47.79%12050.70%-1025.65%-1.80%-5761.42%5512.52%
Return on Capital Employed
100.05%-4.26%12014.16%-1032.30%-130.22%-1834.87%5490.92%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/A1.21N/A
Quick Ratio
N/A3.820.891.212.181.181.03
Cash ratio
N/A3.710.591.182.151.180.88
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/A3.14K5.05K19.81KN/A4.10K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/A0.80N/A
Debt Equity Ratio
N/AN/AN/AN/AN/A4.22N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/A-672.20N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/A
Company Equity Multiplier
-6.231.35-20.535.221.835.22-9.58
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
N/A11.011111.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/A